Literature DB >> 15177888

Plasmid-based generation of recombinant coxsackievirus B3 particles carrying capsid gene replacement replicons.

Ralph G Meyer1, Mirella L Meyer-Ficca, Heike Kaiser, Hans-Christoph Selinka, Reinhard Kandolf, Jan-Heiner Küpper.   

Abstract

Recombinant infectious coxsackievirus B3 (CVB3) particles were generated by packaging of modified viral genomes in which the capsid coding P1-region was replaced by an EGFP-luciferase reporter gene. Efficient packaging of the recombinant genome was achieved by a novel method based on cotransfection of a plasmid encoding the subgenomic viral replicon together with two alternative helper plasmids carrying expression cassettes of the CVB3 capsid proteins, and a T7 RNA polymerase expression plasmid. Transcription of a reporter gene and expression of capsid proteins were achieved in a single step, eliminating the need of a helper virus. Recombinant viral stocks were used to infect human embryonal cardiomyocytes (hCMC) and other cell types, and luciferase activity was measured at different timepoints after infection. Neither progeny virus nor wildtype CVB3 was produced upon infection of target cells, facilitating analyses of infected cells without viral spread. The presence of an IRES sequence upstream of the P1 open reading frame in the helper plasmids was indispensable for the generation of recombinant particles, as no packaging was observed using helper plasmids without this feature. Luciferase data obtained by transfection of reporter plasmids with and without upstream 5'-NTR sequences suggests that the CVB3 IRES facilitates translation in T7 RNA polymerase-dependent gene transcription, both in presence and absence of viral replication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177888     DOI: 10.1016/j.virusres.2004.02.037

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  5 in total

1.  5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.

Authors:  K-S Kim; S Tracy; W Tapprich; J Bailey; C-K Lee; K Kim; W H Barry; N M Chapman
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

2.  Recombinant lentivirus-delivered short hairpin RNAs targeted to conserved coxsackievirus sequences protect against viral myocarditis and improve survival rate in an animal model.

Authors:  Yeon-Jung Kim; Jeonghyun Ahn; Soo-Young Jeung; Dae-Sun Kim; Ha-Na Na; Young-Joo Cho; Soo-Hyeon Yun; Youngmee Jee; Eun-Seok Jeon; Heuiran Lee; Jae-Hwan Nam
Journal:  Virus Genes       Date:  2008-01-03       Impact factor: 2.332

3.  An attenuated coxsackievirus b3 vector: a potential tool for viral tracking study and gene delivery.

Authors:  Jun Zeng; Xiao xuan Chen; Jian ping Dai; Xiang feng Zhao; Gang Xin; Yun Su; Ge fei Wang; Rui Li; Yin xia Yan; Jing hua Su; Yu xue Deng; Kang sheng Li
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

Review 4.  Therapeutic Use of Native and Recombinant Enteroviruses.

Authors:  Jani Ylä-Pelto; Lav Tripathi; Petri Susi
Journal:  Viruses       Date:  2016-02-23       Impact factor: 5.048

5.  Genomic RNA folding mediates assembly of human parechovirus.

Authors:  Shabih Shakeel; Eric C Dykeman; Simon J White; Ari Ora; Joseph J B Cockburn; Sarah J Butcher; Peter G Stockley; Reidun Twarock
Journal:  Nat Commun       Date:  2017-02-23       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.